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Significant progress has been made in the past 3 decades in our understanding of the various causes of loss of
consciousness thanks to the publication of several important studies and guidelines. In particular, the recent
European Society of Cardiology guidelines provide a reference standard for optimal quality service delivery. This
paper gives the reader brief guidance on how to manage a patient with syncope, with reference to the above
guidelines. Despite the progress made, the management of patients with syncope remains largely unsatisfactory
because of the presence of a significant gap between knowledge and its application. Two new concepts aimed
at filling that gap are currently under evaluation: syncope facilities with specialist backup and interactive
decision-making software. Preliminary data have shown that a standardized syncope assessment, especially
when coupled with interactive decision-making software, decreases admission rate and unnecessary testing and
improves diagnostic yield, thus reducing cost per diagnosis. The long-term effects of such a new health care
model on the rate of diagnosis and survival await future studies. (J Am Coll Cardiol 2012;59:1583–91)
© 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.11.056Syncope and Its Context
Definition. Transient loss of consciousness (TLOC) or
faint are generic terms that encompass all disorders charac-
terized by transient, self-limited, nontraumatic loss of con-
sciousness. The causes of TLOC include syncope, epileptic
seizures, psychogenic, and other rare miscellaneous causes.
What differentiates syncope from the other forms of TLOC
is its unique pathophysiology (i.e., transient global cerebral
hypoperfusion due to low peripheral resistances and/or low
cardiac output) (1).
Epidemiology. TLOC events of suspected syncopal nature
are extremely frequent in the general population (2). A
recent epidemiological study performed in the state of Utah
(3) showed that the yearly prevalence of fainting spells
resulting in medical evaluation was 9.5 per 1,000 inhabit-
ants, with 1 out of 10 patients hospitalized. The majority of
patients did not seek medical help, and only a small fraction
saw a specialist or presented to the emergency department
(ED) (Table 1) (2,3). The first-time incidence of syncope by
age is bimodal (1). Its prevalence is very high in patients
between the ages of 10 and 30 years, is uncommon in adults
with an average age of 40 years, and peaks again in patients
older than 65 years. In the Framingham study (4), the
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Prognosis. The outcome in patients with syncope is often
related to the severity of the underlying disease rather than
the syncopal event itself. Structural heart disease and ortho-
static hypotension in the elderly patient are associated with
an increased risk of death due to comorbidities (1,5). In the
EGSYS 2 (Guidelines in Syncope Study 2) follow-up study
(6) including 398 patients who presented to the ED with
syncope, death of any cause occurred in 9.2% of patients
during a mean follow-up of 614 days. Among the patients
who died, 82% had an abnormal electrocardiogram (ECG)
and/or heart disease; conversely, only 6 deaths (3%) oc-
curred in patients without abnormal ECG and/or heart
disease, indicating a negative predictive value of 97%.
Mortality was significantly worse in patients with structural
cardiac or cardiopulmonary cause of syncope compared with
that of patients with other causes of syncope.
Classification and Treatment
Traditionally, the causes of syncope are classified according
to etiology and presumed pathophysiology. Figure 1, left
column, shows the classification of syncope based on etiol-
ogy as proposed by the European Society of Cardiology
(ESC) guidelines (1). Because of recent advances in tech-
nology, our ability to make a diagnosis based on the
documentation of spontaneous events has increased. This
resulted in a new classification based on the underlying
mechanism (7). Figure 1, right column, shows the classifi-
cation of syncope based on mechanism. Classification based
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relate with classification based on
mechanism. The same mecha-
nism of syncope is present in
different etiologies, and any
given etiology can cause syncope
with different mechanisms.
Although reflex syncope is the
most frequent etiology, account-
ing for approximately two-thirds
of cases, long asystolic pauses due
to sinus arrest, atrioventricular
block, or a combination of the
two are the most frequent mechanism of unexplained
syncope occurring in more than one-half of patients (8–21).
The efficacy of therapy is largely determined by the mech-
anism of syncope rather than its etiology. Therapy based on
etiologic diagnosis gave partially unsatisfactory results in
one study (6), showing syncope recurrence in 16.5% of patients
during 614  73 days of follow-up regardless of etiology.
Conversely, in the randomized Eastbourne Syncope Assess-
ment Study (20), patients who received a specific treatment
based on the findings derived from implantable loop record-
ers (ILRs) demonstrated a significant reduction in syncopal
recurrences. In several open or uncontrolled studies, perma-
nent cardiac pacing was highly effective in preventing
syncopal recurrences when an asystolic pause could be
documented at the time of syncope occurrence regardless of
pathophysiology (i.e., intrinsic sinus node disease or extrin-
sic autonomic changes) (8,22–24). Given the better out-
come with mechanism-specific therapy, it is the authors’
opinion that the classification of syncope based on mecha-
nism is likely to become the most widely used approach in
patients presenting with syncope.
Diagnostic Algorithm
There are 2 main reasons for evaluating a patient with
syncope: 1) to assess the prognostic risk, including death,
severe adverse events, and syncope recurrence; and 2) to
identify the specific cause of the loss of consciousness to
apply an effective mechanism-specific treatment strategy.
Defining the mechanism is a prerequisite for finding a
specific therapy to prevent recurrences. The ESC guidelines,
which are summarized in the algorithm shown in Figure 2,
address both issues.
Initial evaluation: the value of history taking and stan-
dard ECG. The first step in the evaluation of a patient
presenting with TLOC of suspected syncopal nature con-
sists of obtaining a detailed history and conducting a
physical examination including orthostatic blood pressure
(BP) measurements and standard ECG. In selected cases,
the initial evaluation may also include echocardiography and
in-hospital ECG monitoring (i.e. telemetry) neurological
consultation, and blood tests (1). The initial evaluation may
Abbreviations
and Acronyms
ECG  electrocardiography
ED  emergency
department
ESC  European Society of
Cardiology
ILR  implantable loop
recorder
TLOC  transient loss of
consciousnesslead to a certain diagnosis in the situations listed in Table 2.Under these circumstances, no further testing is required,
and treatment can be initiated as needed. It is important to
recognize that the diagnostic yield of the initial evaluation
depends on the clinical setting in which the patient is being
evaluated. In 2 large multicenter trials, a diagnosis was
established in 50% of patients evaluated in the ED (25) and
in 21% of the more “difficult” patients referred to specialized
syncope units (26). Reflex syncope (vasovagal, situational)
accounted for approximately two-thirds of the diagnoses in
both settings. Arrhythmic syncope was the second most
frequent cause of syncope, accounting for 10% of the cases.
Assessment and management of patients with a high
short-term risk. The second step in the evaluation of a
patient presenting with TLOC is to assess the probability of
developing serious clinical events within days or weeks of
the index presentation. This risk assessment will determine
the need for immediate hospitalization and early intensive
evaluation (Fig. 2, Table 3).
A recent literature review performed by a task force of
the Canadian Cardiovascular Society (27) showed that on
average 7.5% of patients referred to the ED had nonfatal
severe outcomes while in the ED and 4.5% had nonfatal
severe outcomes in the subsequent 7- to 30-day period. Severe
outcome was defined as new diagnosis, clinical deterio-
ration, syncope recurrence with serious injury, or signif-
icant therapeutic intervention. Furthermore, only 0.7% of
patients died within the same time period. Thus, only a
small minority of patients referred to the ED is likely to
benefit from urgent assessment, and even a smaller subset
requires hospitalization. The challenge resides in accurately
identifying patients with high short-term risk. Table 3
summarizes the recommendations of the ESC and the
Canadian Cardiovascular Society regarding the immediate
need for hospitalization or urgent evaluation. In 3 validation
studies that used the ESC criteria (25,28,29), the admission
rate ranged between 38% and 42%. These admission rates
remained significantly higher than the rate of developing a
serious event shortly after the index presentation. Syncope
facilities have been introduced to decrease the number of
hospitalizations by offering the patient a well-defined rapid
alternative evaluation pathway.
Outpatient evaluation and management of patients with
a low short-term risk. When the preceding high-risk
features are absent, or when they are present with a
subsequent negative workup, the risk of developing a life-
threatening event is low. Indeed, in most of these cases, the
Syncope Frequency Depends on theetting in Which the Measurement Is MadeTable 1 Syncop Fr quency Depends on theSetting in Which the Measurement Is Made
Setting
Incidence
(per 1,000 patient-years) Ratio
General population 18–40 1
Seeking medical evaluation 9.3–9.5 1:2–1:4
Referred for specialty evaluation 3.6 1:5–1:10
Referred to emergency department 0.7–1.8 1:10–1:50Adapted from Olde Nordkamp et al. (2) and Malasana et al. (3).
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patients at low risk with suspected cardiac syncope or reflex
syncope with severe presentation due to the unpredictable
nature of the events or their occurrence in high-risk settings,
outpatient evaluation with referral to a specialized syncope
facility is preferred. In patients with suspected reflex syn-
cope with rare or mild symptoms, no further investigation is
generally warranted. In these instances, patients can be
educated and reassured about the benign nature of their
symptoms (Fig. 2). In patients at low risk with severe
presentation due to the unpredictable nature of the events or
their occurrence in high-risk settings, outpatient evaluation
with referral to a specialized syncope facility is preferred.
Laboratory Provocative Tests Versus
Documentation of Spontaneous Events
Provocative tests are aimed at reproducing syncope or
related abnormalities in an artificial setting (i.e., laboratory).
The assumption is that a positive response to a test
reproduces the mechanism of a spontaneous episode. The
most useful tests and their diagnostic yield are listed in
Table 4. Tilt-table testing and carotid sinus massage are
indicated when reflex syncope is suspected in the setting of
an atypical presentation. Electrophysiological study is indi-
cated when cardiac arrhythmic syncope is suspected such as
in patients with previous myocardial infarction, nondiag-
nostic sinus bradycardia, bundle branch block, or history of
By eology 
(clinical forms)
Reﬂex (neurally-mediated)
Vasovagal
Situaonal    
Carod sinus
Atypical forms (lt-posive)
Orthostac hypotension
Primary autonomic failure
Secondary autonomic failure
Drug-induced
Volume depleon
Cardiac or Cardiovascular
Arrhythmia as primary cause
Bradycardia
Tachycardia
Drug-induced
Structural cardiac (e.g., aorc 
stenosis, atrial mixoma, etc)
Figure 1 Classification of Syncope According to Etiology (Mod
Versus Classification According to Mechanism (Modifi
AV  atrioventricular; BP  blood pressure; ECG  electrocardiogram; ESC  Eur
Etiology.sudden and brief episodes of palpitations preceding thesyncopal event. Exercise testing is indicated in patients who
experience syncope during or shortly after exertion and in
patients with chest pain suggestive of coronary artery
disease. The sensitivity and specificity of any of these tests
are difficult to measure because of the lack in most cases of
a reference or “gold standard.” Therefore, it is important for
the physician to weigh the pre-test probability in his or her
interpretation of a positive response.
Short-term monitoring is useful soon after the index
episode in selected patients who have frequent symptoms
such as weekly occurrences. A generalized use of these tools
in patients with less frequent symptoms is not useful because
of the low probability to record a diagnostic episode.
Because the vast majority of patients with syncope have
infrequent symptoms recurring over months or years, ILRs
are frequently necessary to establish a diagnosis. Pooled data
from 14 studies (8–21) including a total of 1,598 patients
showed an average diagnostic yield of 32% over an obser-
vation period of 18 months and 43% (20), 49% (8), and
approximately 50% (21) when the monitoring period was up
to 2 years. In a recent study (22), extending the monitoring
period up to 4 years safely increased the diagnostic yield of
ILRs up to 80%, with one-quarter of the diagnoses requir-
ing more than 18 months of follow-up (Fig. 3). As a
consequence, when a strategy of prolonged monitoring is
chosen, monitoring should be maintained up to several years
until a diagnosis has been established. In 2 randomized
By mechanism 
(ECG/BP documentaon)
Bradycardia
Asystole
Sinus arrest
Sinus bradycardia plus AV block
AV block
Bradycardia (sinus)
Tachycardia 
Progressive sinus tachycardia
Atrial ﬁbrillaon
Atrial tachycardia (except sinus) 
Ventricular tachycardia
No or slight rhythm variaons-
(Hypotension)
 
by ESC Guidelines [1])
y ISSUE Classification [7])
Society of Cardiology; ISSUE  International Study on Syncope of Uncertainified
ed b
opeanstudies evaluating patients with unexplained syncope, more
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pared with a laboratory approach: 50% versus 20% in one
(12) and 43% versus 6% in the other (20). Despite this
evidence, ILRs are still largely underused in clinical practice,
Figure 2 The Diagnostic Algorithm of a Patient
Presenting With TLOC of Suspected Syncopal Nature
For explanation, see text. ECG  electrocardiogram; TLOC  transient loss of
consciousness.
Established Diagnosis at Initial Evaluation: Commonly Accepted DiTable 2 Established Diagnosis at Initial Evaluation: Commonly
Reflex syncope
● Classical vasovagal syncope is diagnosed if syncope is precipitated by emotional d
and is associated with typical prodromal symptoms due to autonomic activation (i
lightheadedness or dizziness).
● Situational syncope is diagnosed if syncope occurs during or immediately after spe
Gastrointestinal stimulation (swallow, defecation, visceral pain)
Micturition (post-micturition)
Post-exercise
Post-prandial
Cough, sneeze
Others (e.g., laughing, brass instrument playing, weightlifting)
Orthostatic syncope is diagnosed when the history is consistent with the diagnosis a
(usually defined as a decrease in systolic blood pressure 20 mm Hg or a dec
(a fall 30 mm Hg is needed in hypertensive subjects).
Arrhythmia-related syncope is diagnosed by ECG (including ECG monitoring) when th
● Sinus bradycardia 40 beats/min or repetitive sinoatrial blocks or sinus pauses 
● Second-degree Mobitz II or third-degree atrioventricular block
● Alternating left and right bundle branch block
● Paroxysmal supraventricular tachycardia or ventricular tachycardia
● Pacemaker or ICD malfunction with cardiac pauses
Cardiac ischemia-related syncope is diagnosed when symptoms are present with EC
Cardiovascular syncope is diagnosed by echocardiography performed at initial evalu
intracardiac tumors, severe aortic stenosis, pulmonary hypertension, pulmona
obstructive hypertrophic cardiomyopathy, and prosthetic valve dysfunctionECG  electrocardiogram; ICD  implantable cardioverter-defibrillator.with the indication estimated to be 4 times greater than
what has been observed in current practice (30).
In conclusion, the strategy of laboratory tests has the
advantage of providing an immediate diagnosis but is
hampered by a significant risk of misdiagnosis. Conversely,
the strategy of prolonged monitoring provides reliable
evidence of the syncope mechanism but has 2 important
disadvantages: 1) diagnosis and therapy are delayed often for
a long time until an arrhythmic event can be documented;
and 2) hypotensive events in the absence of an arrhythmia
cannot be confirmed given the limitations of the current
monitoring technology.
The Magnitude of the Care Gap in
the Evaluation of Patients With Syncope
Despite the development of guidelines based on the best
available scientific evidence, the dissemination of these
concepts into clinical practice remains a challenge. Educat-
ing every physician who is likely to be involved in the care
of patients presenting with syncope is virtually impossible.
As a result, we see inappropriate use of diagnostic tests, a
high number of patients with misdiagnoses or without a
diagnosis, and excessive use of health care resources. Indeed,
several studies have shown great interhospital and interde-
partmental heterogeneity regarding the incidence of emer-
gency admissions, in-hospital diagnostic pathways, and rate
of diagnosis (2,31–37). For example, in the EGSYS 1 trial
(31) including 996 consecutive patients who presented to
the ED with syncope, carotid sinus massage and head-up
tilt tests were performed in 0% to 58% and 0% to 50% of the
stic Criteriapted Diagnostic Criteria
(such as fear, severe pain, instrumentation, blood phobia) or prolonged standing
pallor, sweating, nausea, feeling of warmth, odd sensation in the abdomen, and
iggers:
re is documentation of orthostatic hypotension during an active standing test
of systolic blood pressure to 90 mm Hg) associated with syncope or pre-syncope
ence of acute ischemia with or without myocardial infarction
hen syncope presents in patients with prolapsing atrial myxoma or other
olus or other hypoxic states, acute aortic dissection, pericardial tamponade,agnoAcce
istress
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performed in 3% to 90% of patients. Consequently, the final
diagnosis of reflex-mediated syncope ranged from 10% to
79%. In a recent study performed at the University of Utah
(38), we also found important discrepancies between clinical
practice and the recommended guidelines. In some in-
stances, tests were performed in the absence of clear
indications, and conversely in other instances, many tests
should have been performed and were not; 36% of admis-
sions did not meet the indications suggested by the ESC
guidelines, and 38% of the final diagnoses were not suffi-
ciently supported.
How to fill the gap? The need to adopt a standardized
approach in clinical practice. To maximize implementa-
tion of the guidelines, it is essential that standardized
models of care for the assessment and management of
syncope are in place. In the next section, we describe 2 new
concepts aimed at filling the gap between science and
clinical practice: syncope facilities and interactive decision-
making software.
Syncope Facilities, Algorithms, and
Interactive Decision-Making Software
The introduction in clinical practice of syncope facilities and
standardized guideline-based algorithms coupled with on-
line decision-making software bring promise and hope to
our struggle to improve patient care.
Short-Term High-Risk Criteria That Require Prompt HospitalizationTable 3 Short-Term High-Risk Criteria That Require Prompt Hos
ESC Guidelines (1)
Severe structural or coronary artery disease (heart failure, low ejection fraction,
or previous myocardial infarction)
ECG features suggesting arrhythmic syncope (nonsustained ventricular tachycardia,
bifascicular block, inadequate sinus bradycardia (50 beats/min) or sinoatrial
block, pre-excited QRS complex, ECG findings suggesting an inherited disease)
Clinical features suggesting arrhythmic syncope (syncope during exertion or
supine position, palpitations at the time of syncope, family history of
sudden cardiac death)
Important comorbidities:
● Severe anemia
● Electrolyte disturbance
ECG  electrocardiogram; ESC  European Society of Cardiology.
Diagnostic Yield of the Most Used Tests for Diagnosis ofUncertain Syncope After Ini ial Evaluation in 2 Different Clinical SeTable 4 Diagnostic Yield of the Mo t Used Test for D agnosisUncertain Syncope After Initial Evaluation in 2 Differen
Emergency Departme
Performed, Patients Diag
Tilt testing 76 (43%)
Carotid sinus massage 65 (37%)
Prolonged ECG monitoring (Holter, telemetry,
external loop recorder)
16 (9%)
Exercise test 10 (6%)
Electrophysiological study 15 (9%)
Coronary angiography 8 (5%)Values are n (%). *EGSYS 2 (Evaluation of Guidelines in Syncope Study 2) (25). †SUP (Syncope Unit Proj
NND  number needed for diagnosis; other abbreviation as in Table 1.Specialized syncope facilities: “the right physician, in the
right place, at the right time.” It was the view in the 2004
ESC syncope guidelines that a cohesive structured care
pathway delivered either within a single syncope facility
(i.e., syncope unit) or a multifaceted service is needed to
optimize the quality of service delivered to patients with
syncope (39). The ESC guidelines did not provide concrete
recommendations but only a framework of the general
standards. The goals of syncope facilities are to: 1) provide
a standardized assessment by a syncope specialist and
continuity of care starting with the initial evaluation and
including therapy and follow-up; and 2) reduce the rate of
hospitalization by offering the patient a well-defined rapid
alternative evaluation pathway.
In general, a syncope facility should be led by a syncope
specialist, who is a single physician or a team of physicians
that should manage all aspects of patient care, including the
initial diagnosis, risk assessment, therapy, and follow-up.
He or she should perform the core laboratory tests and must
have access to hospital beds, diagnostic tests, and therapeu-
tic procedures. The syncope facility should be multidisci-
plinary with access to physicians and nurses experienced in
key components of cardiology, neurology, emergency, and
geriatric medicine. A syncope facility should have:
• Core equipment: ECG recorders, continuous BP
monitors, tilt table, external and implantable ECG
monitoring systems, 24-h ambulatory BP monitoring,
rly Intensive Evaluationization or Early Intensive Evaluation
Canadian Cardiovascular Society Position Paper (29)
Heart failure and history of cardiac disease (ischemic, arrhythmic,
obstructive, valvular)
Abnormal ECG (any bradyarrhythmia, tachyarrhythmia, or conduction
disease; new ischemia or old infarct)
Hypotension (systolic blood pressure 90 mm Hg)
Minor risk factors deserving urgent specialist assessment: age 60 years,
dyspnea, anemia (hematocrit 0.30), hypertension, cerebrovascular
disease, family history of sudden death 50 years, syncope while
supine, syncope during exercise, syncope with no prodromal symptoms
s
ical Settings
 175) Syncope Unit† (n  673)
, Tests NND Performed, Patients Diagnostic, Tests NND
%) 1.6 443 (66%) 237 (53%) 1.9
%) 3.6 509 (76%) 62 (12%) 8.2
%) 3.2 175 (26%) 15 (9%) 12.0
%) 3.3 41 (6%) 1 (2%) 41.0
%) 3.0 40 (6%) 14 (35%) 2.9
%) 1.6 14 (2%) 1 (7%) 14.0or Eapitalttingof
t Clin
nt* (n
nostic
46 (61
18 (28
5 (31
3 (30
3 (30
5 (62ect) study (26).
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Algorithms coupled with interactive decision-making
software (see next section) and dedicated rooms for
assessment and investigation are also recommended.
• Fast track access with a separate waiting list and
scheduled follow-up visits.
• On-site preferential access to specialized tests: echocar-
diography, invasive electrophysiological testing, coronary
angiography, stress testing, computed tomography, mag-
netic resonance imaging, and electroencephalography
should be available to the caring physician. Easy access
to hospital beds for dedicated therapeutic procedures
(e.g., pacemaker, defibrillator implantation, catheter
ablation) is essential.
Since the publication of the ESC document, many
nvestigators have shown in uncontrolled studies that the
se of specialized syncope facilities led to an improvement in
iagnostic yield and cost effectiveness (i.e., cost per reliable
iagnosis) (28,29,40–43). In a randomized controlled
tudy, Shen et al. (44) found that a designated syncope unit
n the ED significantly improved diagnostic yield, reduced
ospital admissions, and reduced total length of hospital
tay without affecting recurrent syncope and all-cause mor-
ality when compared with standard care. Probably the
argest reported real-world experience is that of the SUP
Syncope Unit Project) study (26). This prospective multi-
enter study documented the current practice of 9 syncope
nits in Italy. The study enrolled 941 consecutive patients
ffected by unexplained TLOC from March 15, 2008, to
eptember 15, 2008. The majority of patients (60%) were
eferred from out-of-hospital services, 11% and 13% were
mmediate and delayed referral, respectively, from the ED
so-called “protected discharge” with an appointment for
Figure 3 Time-Dependent Cumulative Diagnostic Yield of ILR
The actuarial curve with its 95% confidence intervals is presented.
ILR  implantable loop recorder.arly assessment), and 16% were hospitalized patients. A wiagnosis was established on initial evaluation in 191 pa-
ients (21%) and early by a mean of 2.9  1.6 tests in 541
atients (61%). A likely reflex cause was established in 67%,
rthostatic hypotension in 4%, cardiac in 6%, and nonsyn-
opal in 5% of the cases. The cause of syncope remained
nexplained in 159 patients (18%), despite a mean of 3.5 
.8 tests per patient.
lgorithms coupled with interactive decision-making
oftware. A web-based online interactive decision-making
lgorithm is another promising tool that could help physi-
ians in their attempts to follow the guidelines. In addition
o posting educational material, such access could also help
rovide suggestions regarding the most appropriate
vidence-based therapy. Because such software were never
ntended to be surrogates to a physician’s skills and judg-
ent, use of the software would still require a physician
xpert in the field who can take care of and manage these
atients.
The software concept was first tested in the EGSYS 2
tudy (25). Keeping with the requirements, the authors used
ecision-making software based on the ESC guidelines and
nsured the presence of a trained physician at each of the
articipating hospitals. The designated physician was
ranted access to a specialist who is knowledgeable about
he management of patients with syncope. The strategy led
o adherence to a guideline approach in 86% of 541 patients
nd yielded a diagnosis in 98% of cases. Important limita-
ions included the exclusion of outpatients and the required
vailability of a “syncope expert” by phone to provide advice.
n another study, a direct but nonrandomized comparison
as made between 745 patients from 18 hospitals that
dopted the same standardized care model and 929 patients
rom another 28 hospitals that used the conventional
ethod (45). The standardized care strategy resulted in
mproved diagnostic yield (95% vs. 80%), reduced admission
ate (39% vs. 47%), shorter in-hospital stay (7.2 vs. 8.1
ays), fewer tests performed per patient (median 2.6 vs. 3.4),
nd 19% reduction in cost.
Recently we developed at the University of Utah a faint
lgorithm that incorporated the most recent ESC guidelines
Fig. 4). The software was validated in 2 studies. In the first
tudy (46), we found that 6% of the discharges and 58% of
he admissions from the ED were not in accordance with
he ESC guidelines. The adoption of the faint algorithm
ould have resulted in a 52% reduction in admission rate
ithout a significant difference in the prevalence of serious
vents in the discharged group. In the second study, we
valuated prospectively the incremental value of the faint
lgorithm in the outpatient setting. We found that the use
f such an algorithm resulted in a significant decrease in the
umber of admissions (2% vs. 16%; p  0.001) and a
ignificant increase in the number of diagnoses during the
rst 45 days of workup (57% vs. 39%; p  0.02). In
ddition, the number of tests or consultations resulting in
dditional charges was significantly lower when compared
ith conventional methods (1.9  1.0 vs. 2.6  1.2; p 
1589JACC Vol. 59, No. 18, 2012 Brignole and Hamdan
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The case of a patient referred for unexplained syncope without ECG abnormalities or structural heart disease is shown. After all of the essential information obtained
from history, physical examination, 12-lead ECG, echocardiogram, and appropriate blood tests was entered, the software determined the short-term risk and need for
admission (A, red arrow). If the decision is made not to admit the patient, the software uses the available information to verify whether a certain diagnosis can be
made or not as defined in the recent ESC guidelines. If no diagnosis can be made, the software suggests the most likely diagnosis (B, red arrow) and recommends the
appropriate tests to be performed in a sequential manner, resulting in cost-effective practices (C, red arrow). At any step, the health care provider is given the opportu-
nity to agree or disagree with the software recommendation. In addition, he or she has access to the most recent educational material, including the guidelines, by click-
ing on the “?” button. AHA  American Heart Association; TIA  transient ischemic attack; other abbreviations as in Figure 1.
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New Concepts in Syncope May 1, 2012:1583–910.001). This latter finding was primarily the result of a less
frequent use of brain computed tomography and magnetic
resonance imaging scans and a more frequent use of
orthostatic BP measurements, tilt-table testing, and carotid
sinus massage. Not surprisingly, the cost per diagnosis also
decreased.
In conclusion, we would like to quote a recent docu-
ment published by the Canadian Cardiovascular Society
(28) in which the authors concluded that after a thorough
review of the available English, Italian, and American
experiences, formal syncope facilities increased diagnostic
yield, prevented unnecessary admissions and tests, and
reduced costs. This fact may be explained by the adoption
of standardized diagnostic pathways, increased ease of
access to specialists and related tests, and provision of an
online prompting tool.
Conclusions
Significant progress has been made in the past 3 decades in
our understanding of the various causes of loss of conscious-
ness. Nevertheless, the management of these patients is still
largely unsatisfactory because of the presence of a significant
gap between knowledge and its application to practice.
Preliminary data have shown that a standardized syncope
assessment, especially when coupled with interactive
decision-making software decreases admissions and unnec-
essary testing and improves diagnostic yield, thus reducing
cost per diagnosis. Indeed, the presence of a syncope
specialist (“the right physician”), adequate equipment
including online prompting tools and logistics (“the right
place”), and optimal organization (“the right time”), as
exemplified in a syncope facility, have been shown to
improve at least short-term outcomes. Their relative
contribution to the care of the patient is difficult to
ascertain. The long-term effects of such a new health care
model on the rate of diagnosis and survival awaits future
studies. Regardless of the structure and facility, a standard-
ized approach is undoubtedly the most important prerequi-
site for the delivery of the best and most cost-effective
therapy in patients presenting with syncope.
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